The AHA’s Health Research & Educational Trust affiliate and the Centers for Disease Control and Prevention today announced a three-year initiative to improve the implementation of infection prevention and control efforts in U.S. hospitals. The project will work with state hospital associations, state health departments, the Centers for Medicare & Medicaid Services’ Quality Improvement Networks, AHA’s American Society for Healthcare Engineering affiliate and other partners to reduce central line-associated bloodstream infections, catheter-associated urinary tract infections, Clostridium difficile infections and methicillin-resistant Staphylococcus aureus infections in targeted acute care hospitals. “We welcome the opportunity to work with CDC on the important issue of infection prevention,” said Maulik Joshi, president of HRET and associate executive vice president of AHA. “This project will build on our national work that has successfully reduced CAUTI and CLABSI rates and improved patient care.”

Related News Articles

Headline
Terry Fulmer, Ph.D., R.N., president of the John A. Hartford Foundation, explains in a new blog how its "4Ms" care model aligns with AHA's Patient Safety…
Headline
Antimicrobial-resistant infections remained above pre-pandemic levels in 2022, the Centers for Disease Control and Prevention reported July 16. CDC data show…
Headline
The Centers for Disease Control and Prevention July 14 announced four confirmed human cases of H5N1 bird flu among farm workers who were working at a Colorado…
Perspective
Patient safety is the top priority of every caregiver. Hospitals and health systems never stop searching for ways to improve quality, performance and results…
Blog
The greatest success story of the 20th century is longevity. This is especially true in the United States, where average life expectancy at birth rose by more…
Headline
The AHA the week of July 8 released its Quality Collective Report, which explores quality, safety and performance improvement strategies and insights from…